Science / March 03, 2024
A Phase 1/2 study of NS-050/NCNP-03, an investigational exon 50 skipping therapy, in boys with Duchenne muscular dystrophy (Meteor50): Trial design
Download
Press Release / July 01, 2025
Read more
Press Release / January 23, 2025
News / October 02, 2024